2024 Q3 Form 10-Q Financial Statement

#000095017024122588 Filed on November 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q3
Revenue $9.201M
YoY Change -17.62%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $1.648M
YoY Change -15.4%
Operating Profit $7.641M
YoY Change -18.19%
Interest Expense $67.74K
YoY Change 86.36%
% of Operating Profit 0.89%
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings $59.77M
YoY Change 353.99%
Net Earnings / Revenue 649.63%
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 28.35M
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $752.4M
YoY Change -9.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $13.84M
YoY Change -28.45%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $738.5M
YoY Change
Total Liabilities & Shareholders Equity $752.4M
YoY Change -9.83%

Cashflow Statement

Concept 2024 Q3
OPERATING ACTIVITIES
Net Income $59.77M
YoY Change 353.99%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001383082
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2025-09-30
us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2024-11-30
us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2025-07-31
us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2025-07-31
us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2024-11-30
us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2024-12-31
us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2024-12-31
us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2024-12-31
us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2024-12-31
us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2024-12-31
us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2025-06-30
CY2023 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2024-09-30
CY2023 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2024-11-30
CY2023 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2024-07-31
CY2023 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2024-07-31
CY2023 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2024-03-31
CY2023 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2024-02-29
CY2023 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2024-02-29
CY2023 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2024-03-31
CY2023 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2024-03-31
CY2023 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2024-03-31
CY2023 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2024-06-30
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-33238
dei Entity Registrant Name
EntityRegistrantName
INVESCO DB AGRICULTURE FUND
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-0778078
dei Entity Address Address Line1
EntityAddressAddressLine1
c/o Invesco Capital Management LLC
dei Entity Address Address Line2
EntityAddressAddressLine2
3500 Lacey Road
dei Entity Address Address Line3
EntityAddressAddressLine3
Suite 700
dei Entity Address City Or Town
EntityAddressCityOrTown
Downers Grove
dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60515
dei City Area Code
CityAreaCode
800
dei Local Phone Number
LocalPhoneNumber
983-0903
dei Security12b Title
Security12bTitle
Common Units of Beneficial Interest
dei Trading Symbol
TradingSymbol
DBA
dei Security Exchange Name
SecurityExchangeName
NYSEArca
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
28350000
CY2024Q3 us-gaap Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
297686525
CY2023Q4 us-gaap Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
342956644
CY2023Q4 us-gaap Cash
Cash
4721066
CY2023Q4 dba Receivable From Fund Shares Sold
ReceivableFromFundSharesSold
2074305
CY2024Q3 us-gaap Dividends Receivable
DividendsReceivable
1214425
CY2023Q4 us-gaap Dividends Receivable
DividendsReceivable
1403400
CY2024Q3 us-gaap Assets
Assets
752369370
CY2023Q4 us-gaap Assets
Assets
718970873
CY2024Q3 dba Payable To Clearing Organizations
PayableToClearingOrganizations
13370792
CY2023Q4 dba Payable To Clearing Organizations
PayableToClearingOrganizations
10687335
CY2023Q4 us-gaap Distribution Payable
DistributionPayable
336157
CY2023Q4 dba Payable For Fund Shares Reacquired
PayableForFundSharesReacquired
3157545
CY2024Q3 us-gaap Management Fee Payable
ManagementFeePayable
465337
CY2023Q4 us-gaap Management Fee Payable
ManagementFeePayable
520593
CY2024Q3 us-gaap Commissions Payable To Broker Dealers And Clearing Organizations
CommissionsPayableToBrokerDealersAndClearingOrganizations
5028
CY2023Q4 us-gaap Commissions Payable To Broker Dealers And Clearing Organizations
CommissionsPayableToBrokerDealersAndClearingOrganizations
2673
CY2024Q3 us-gaap Liabilities
Liabilities
13841157
CY2023Q4 us-gaap Liabilities
Liabilities
14704303
CY2024Q3 us-gaap General Partners Capital Account
GeneralPartnersCapitalAccount
1042
CY2023Q4 us-gaap General Partners Capital Account
GeneralPartnersCapitalAccount
830
CY2024Q3 us-gaap Limited Partners Capital Account
LimitedPartnersCapitalAccount
738527171
CY2023Q4 us-gaap Limited Partners Capital Account
LimitedPartnersCapitalAccount
704265740
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
738528213
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
704266570
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
752369370
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
718970873
CY2024Q3 us-gaap General Partners Capital Account Units Outstanding
GeneralPartnersCapitalAccountUnitsOutstanding
40
CY2023Q4 us-gaap General Partners Capital Account Units Outstanding
GeneralPartnersCapitalAccountUnitsOutstanding
40
CY2024Q3 us-gaap Limited Partners Capital Account Units Outstanding
LimitedPartnersCapitalAccountUnitsOutstanding
28350000
CY2023Q4 us-gaap Limited Partners Capital Account Units Outstanding
LimitedPartnersCapitalAccountUnitsOutstanding
33950000
CY2024Q3 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
26.05
CY2023Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
20.74
CY2024Q3 dba Market Value Per Share
MarketValuePerShare
26.10
CY2023Q4 dba Market Value Per Share
MarketValuePerShare
20.73
CY2024Q3 us-gaap Investment Interest Rate
InvestmentInterestRate
0.0498
CY2024Q3 us-gaap Investment Maturity Date
InvestmentMaturityDate
2024-11-29
CY2024Q3 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.3695
CY2024Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
272890186
CY2024Q3 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
275000000
CY2024Q3 us-gaap Investment Interest Rate
InvestmentInterestRate
0.0497
CY2024Q3 us-gaap Investment Maturity Date
InvestmentMaturityDate
2024-12-05
CY2024Q3 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.0336
CY2024Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
24796339
CY2024Q3 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
25000000
CY2024Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
297391008
CY2024Q3 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.4031
CY2024Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
297686525
CY2024Q3 dba Investments In And Advances To Affiliates At Cost
InvestmentsInAndAdvancesToAffiliatesAtCost
119520055
CY2024Q3 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.1622
CY2024Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
119797308
CY2024Q3 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
1133800
CY2024Q3 us-gaap Investment Interest Rate
InvestmentInterestRate
0.0485
CY2024Q3 dba Investments In And Advances To Affiliates At Cost
InvestmentsInAndAdvancesToAffiliatesAtCost
333671112
CY2024Q3 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.4518
CY2024Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
333671112
CY2024Q3 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
333671112
CY2024Q3 dba Investments In And Advances To Affiliates At Cost
InvestmentsInAndAdvancesToAffiliatesAtCost
453191167
CY2024Q3 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.614
CY2024Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
453468420
CY2024Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
750582175
CY2024Q3 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
1.0171
CY2024Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
751154945
CY2024Q3 us-gaap Good Faith And Margin Deposits With Broker Dealers
GoodFaithAndMarginDepositsWithBrokerDealers
148845000
CY2024Q3 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
2686
CY2024Q3 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
60367850
CY2024Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1145092
CY2024Q3 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
1145092
CY2024Q3 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
1210
CY2024Q3 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
63948500
CY2024Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
-11829019
CY2024Q3 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
-11829019
CY2024Q3 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
1084
CY2024Q3 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
33658200
CY2024Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
-5307762
CY2024Q3 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
-5307762
CY2024Q3 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
1089
CY2024Q3 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
33377850
CY2024Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
-5761667
CY2024Q3 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
-5761667
CY2024Q3 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
210
CY2024Q3 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
25714500
CY2024Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1365208
CY2024Q3 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
1365208
CY2024Q3 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
1777
CY2024Q3 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
52083870
CY2024Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1125734
CY2024Q3 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
1125734
CY2024Q3 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
1108
CY2024Q3 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
81903360
CY2024Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
3552553
CY2024Q3 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
3552553
CY2024Q3 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
2478
CY2024Q3 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
191351160
CY2024Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
23658300
CY2024Q3 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
23658300
CY2024Q3 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
1118
CY2024Q3 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
113302313
CY2024Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
15176681
CY2024Q3 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
15176681
CY2024Q3 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
442
CY2024Q3 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
16267810
CY2024Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
134983
CY2024Q3 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
134983
CY2024Q3 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
2916
CY2024Q3 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
65710310
CY2024Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
5625397
CY2024Q3 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
5625397
CY2024Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
28885500
CY2024Q3 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
28885500
CY2023Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.0525
CY2023Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2024-03-07
CY2023Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.0352
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
24765221
CY2023Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
25000000
CY2023Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.0524
CY2023Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2024-05-30
CY2023Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.4171
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
293737965
CY2023Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
300000000
CY2023Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.0519
CY2023Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2024-06-06
CY2023Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.0347
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
24453458
CY2023Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
25000000
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
342604310
CY2023Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.487
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
342956644
CY2023Q4 dba Investments In And Advances To Affiliates At Cost
InvestmentsInAndAdvancesToAffiliatesAtCost
119520055
CY2023Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.1699
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
119734949
CY2023Q4 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
1133800
CY2023Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.0529
CY2023Q4 dba Investments In And Advances To Affiliates At Cost
InvestmentsInAndAdvancesToAffiliatesAtCost
248080509
CY2023Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.3523
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
248080509
CY2023Q4 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
248080509
CY2023Q4 dba Investments In And Advances To Affiliates At Cost
InvestmentsInAndAdvancesToAffiliatesAtCost
367600564
CY2023Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.5222
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
367815458
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
710204874
CY2023Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
1.0092
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
710772102
CY2023Q4 us-gaap Good Faith And Margin Deposits With Broker Dealers
GoodFaithAndMarginDepositsWithBrokerDealers
146865000
CY2023Q4 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
3564
CY2023Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
88565400
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
-2696057
CY2023Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
-2696057
CY2023Q4 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
1405
CY2023Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
87513938
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
-1282131
CY2023Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
-1282131
CY2023Q4 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
1401
CY2023Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
45234788
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
-1339435
CY2023Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
-1339435
CY2023Q4 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
1338
CY2023Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
43217400
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
-5650533
CY2023Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
-5650533
CY2023Q4 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
258
CY2023Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
28779900
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1161102
CY2023Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
1161102
CY2023Q4 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
2023
CY2023Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
55005370
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
-5957186
CY2023Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
-5957186
CY2023Q4 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
1265
CY2023Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
85261000
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
-6678115
CY2023Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
-6678115
CY2023Q4 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
2052
CY2023Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
86101920
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
5543802
CY2023Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
5543802
CY2023Q4 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
1250
CY2023Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
88265625
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
8413856
CY2023Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
8413856
CY2023Q4 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
519
CY2023Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
21019500
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
325083
CY2023Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
325083
CY2023Q4 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
3282
CY2023Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
75023894
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
-9139633
CY2023Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
-9139633
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
-17299247
CY2023Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
-17299247
CY2024Q3 us-gaap Interest Income Operating
InterestIncomeOperating
3986652
CY2023Q3 us-gaap Interest Income Operating
InterestIncomeOperating
4788543
us-gaap Interest Income Operating
InterestIncomeOperating
12798318
us-gaap Interest Income Operating
InterestIncomeOperating
14291035
CY2024Q3 us-gaap Dividend Income Operating
DividendIncomeOperating
5213894
CY2023Q3 us-gaap Dividend Income Operating
DividendIncomeOperating
6380385
us-gaap Dividend Income Operating
DividendIncomeOperating
16090976
us-gaap Dividend Income Operating
DividendIncomeOperating
18235721
CY2024Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
9200546
CY2023Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
11168928
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
28889294
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
32526756
CY2024Q3 us-gaap Investment Company General Partner Advisory Service
InvestmentCompanyGeneralPartnerAdvisoryService
1491660
CY2023Q3 us-gaap Investment Company General Partner Advisory Service
InvestmentCompanyGeneralPartnerAdvisoryService
1799485
us-gaap Investment Company General Partner Advisory Service
InvestmentCompanyGeneralPartnerAdvisoryService
4653909
us-gaap Investment Company General Partner Advisory Service
InvestmentCompanyGeneralPartnerAdvisoryService
5722675
CY2024Q3 us-gaap Floor Brokerage Exchange And Clearance Fees
FloorBrokerageExchangeAndClearanceFees
88137
CY2023Q3 us-gaap Floor Brokerage Exchange And Clearance Fees
FloorBrokerageExchangeAndClearanceFees
111690
us-gaap Floor Brokerage Exchange And Clearance Fees
FloorBrokerageExchangeAndClearanceFees
296743
us-gaap Floor Brokerage Exchange And Clearance Fees
FloorBrokerageExchangeAndClearanceFees
423216
CY2024Q3 us-gaap Interest Expense
InterestExpense
67742
CY2023Q3 us-gaap Interest Expense
InterestExpense
36350
us-gaap Interest Expense
InterestExpense
159882
us-gaap Interest Expense
InterestExpense
109570
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
1647539
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
1947525
us-gaap Operating Expenses
OperatingExpenses
5110534
us-gaap Operating Expenses
OperatingExpenses
6255461
CY2024Q3 us-gaap Investment Company Contractual Fee Waived
InvestmentCompanyContractualFeeWaived
87709
CY2023Q3 us-gaap Investment Company Contractual Fee Waived
InvestmentCompanyContractualFeeWaived
118617
us-gaap Investment Company Contractual Fee Waived
InvestmentCompanyContractualFeeWaived
276023
us-gaap Investment Company Contractual Fee Waived
InvestmentCompanyContractualFeeWaived
352996
CY2024Q3 dba Operating Expenses Net
OperatingExpensesNet
1559830
CY2023Q3 dba Operating Expenses Net
OperatingExpensesNet
1828908
dba Operating Expenses Net
OperatingExpensesNet
4834511
dba Operating Expenses Net
OperatingExpensesNet
5902465
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
7640716
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
9340020
us-gaap Operating Income Loss
OperatingIncomeLoss
24054783
us-gaap Operating Income Loss
OperatingIncomeLoss
26624291
CY2024Q3 dba Net Realized Gain Loss From United States Treasury Obligations
NetRealizedGainLossFromUnitedStatesTreasuryObligations
1
CY2023Q3 dba Net Realized Gain Loss From United States Treasury Obligations
NetRealizedGainLossFromUnitedStatesTreasuryObligations
139
dba Net Realized Gain Loss From United States Treasury Obligations
NetRealizedGainLossFromUnitedStatesTreasuryObligations
3
dba Net Realized Gain Loss From United States Treasury Obligations
NetRealizedGainLossFromUnitedStatesTreasuryObligations
74
CY2024Q3 us-gaap Gain Loss On Sale Of Commodity Contracts
GainLossOnSaleOfCommodityContracts
-33542099
CY2023Q3 us-gaap Gain Loss On Sale Of Commodity Contracts
GainLossOnSaleOfCommodityContracts
12986866
us-gaap Gain Loss On Sale Of Commodity Contracts
GainLossOnSaleOfCommodityContracts
91999404
us-gaap Gain Loss On Sale Of Commodity Contracts
GainLossOnSaleOfCommodityContracts
31335023
CY2024Q3 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-33542098
CY2023Q3 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
12987005
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
91999407
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
31335097
CY2024Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
199797
CY2023Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-178241
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-56817
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-96119
CY2024Q3 dba Unrealized Gain Loss On Affiliated Investments
UnrealizedGainLossOnAffiliatedInvestments
215423
CY2023Q3 dba Unrealized Gain Loss On Affiliated Investments
UnrealizedGainLossOnAffiliatedInvestments
34014
dba Unrealized Gain Loss On Affiliated Investments
UnrealizedGainLossOnAffiliatedInvestments
62359
dba Unrealized Gain Loss On Affiliated Investments
UnrealizedGainLossOnAffiliatedInvestments
160015
CY2024Q3 us-gaap Unrealized Gain Loss On Commodity Contracts
UnrealizedGainLossOnCommodityContracts
85256092
CY2023Q3 us-gaap Unrealized Gain Loss On Commodity Contracts
UnrealizedGainLossOnCommodityContracts
-9017234
us-gaap Unrealized Gain Loss On Commodity Contracts
UnrealizedGainLossOnCommodityContracts
46184747
us-gaap Unrealized Gain Loss On Commodity Contracts
UnrealizedGainLossOnCommodityContracts
-8085031
CY2024Q3 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
85671312
CY2023Q3 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-9161461
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
46190289
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-8021135
CY2024Q3 us-gaap Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency
InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency
52129214
CY2023Q3 us-gaap Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency
InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency
3825544
us-gaap Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency
InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency
138189696
us-gaap Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency
InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency
23313962
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
59769930
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
13165564
us-gaap Net Income Loss
NetIncomeLoss
162244479
us-gaap Net Income Loss
NetIncomeLoss
49938253
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
709207863
CY2024Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10179118
CY2024Q3 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
40628698
CY2024Q3 dba Stockholders Equity Period Increase Decrease Due To Share Transactions
StockholdersEquityPeriodIncreaseDecreaseDueToShareTransactions
-30449580
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
7640716
CY2024Q3 us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
-33542098
CY2024Q3 dba Net Change In Unrealized Gains Loss On United States Treasury Obligations Affliated Investments And Commodity Futures Contracts
NetChangeInUnrealizedGainsLossOnUnitedStatesTreasuryObligationsAffliatedInvestmentsAndCommodityFuturesContracts
85671312
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
59769930
CY2024Q3 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
29320350
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
738528213
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
836535742
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
17302168
CY2023Q3 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
51931428
CY2023Q3 dba Stockholders Equity Period Increase Decrease Due To Share Transactions
StockholdersEquityPeriodIncreaseDecreaseDueToShareTransactions
-34629260
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
9340020
CY2023Q3 us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
12987005
CY2023Q3 dba Net Change In Unrealized Gains Loss On United States Treasury Obligations Affliated Investments And Commodity Futures Contracts
NetChangeInUnrealizedGainsLossOnUnitedStatesTreasuryObligationsAffliatedInvestmentsAndCommodityFuturesContracts
-9161461
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
13165564
CY2023Q3 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
-21463696
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
815072046
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
704266570
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
94302137
us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
222284973
dba Stockholders Equity Period Increase Decrease Due To Share Transactions
StockholdersEquityPeriodIncreaseDecreaseDueToShareTransactions
-127982836
us-gaap Operating Income Loss
OperatingIncomeLoss
24054783
us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
91999407
dba Net Change In Unrealized Gains Loss On United States Treasury Obligations Affliated Investments And Commodity Futures Contracts
NetChangeInUnrealizedGainsLossOnUnitedStatesTreasuryObligationsAffliatedInvestmentsAndCommodityFuturesContracts
46190289
us-gaap Net Income Loss
NetIncomeLoss
162244479
us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
34261643
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
738528213
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1072706930
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
95514366
us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
403087503
dba Stockholders Equity Period Increase Decrease Due To Share Transactions
StockholdersEquityPeriodIncreaseDecreaseDueToShareTransactions
-307573137
us-gaap Operating Income Loss
OperatingIncomeLoss
26624291
us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
31335097
dba Net Change In Unrealized Gains Loss On United States Treasury Obligations Affliated Investments And Commodity Futures Contracts
NetChangeInUnrealizedGainsLossOnUnitedStatesTreasuryObligationsAffliatedInvestmentsAndCommodityFuturesContracts
-8021135
us-gaap Net Income Loss
NetIncomeLoss
49938253
us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
-257634884
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
815072046
us-gaap Net Income Loss
NetIncomeLoss
162244479
us-gaap Net Income Loss
NetIncomeLoss
49938253
us-gaap Payments For Purchase Of Securities Operating Activities
PaymentsForPurchaseOfSecuritiesOperatingActivities
292121235
us-gaap Payments For Purchase Of Securities Operating Activities
PaymentsForPurchaseOfSecuritiesOperatingActivities
760806844
us-gaap Proceeds From Sale Of Securities Operating Activities
ProceedsFromSaleOfSecuritiesOperatingActivities
350000000
us-gaap Proceeds From Sale Of Securities Operating Activities
ProceedsFromSaleOfSecuritiesOperatingActivities
1000000074
dba Cost Of Affiliated Investments Purchased
CostOfAffiliatedInvestmentsPurchased
744541217
dba Cost Of Affiliated Investments Purchased
CostOfAffiliatedInvestmentsPurchased
1305351780
dba Proceeds From Affiliated Investments Sold
ProceedsFromAffiliatedInvestmentsSold
658950614
dba Proceeds From Affiliated Investments Sold
ProceedsFromAffiliatedInvestmentsSold
1336838339
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
-12665460
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
-14150453
dba Realized Gain Loss On Marketable Securities And Affiliated Investments
RealizedGainLossOnMarketableSecuritiesAndAffiliatedInvestments
3
dba Realized Gain Loss On Marketable Securities And Affiliated Investments
RealizedGainLossOnMarketableSecuritiesAndAffiliatedInvestments
74
dba Unrealized Gain Loss On Marketable Securities And Affiliated Investments
UnrealizedGainLossOnMarketableSecuritiesAndAffiliatedInvestments
5542
dba Unrealized Gain Loss On Marketable Securities And Affiliated Investments
UnrealizedGainLossOnMarketableSecuritiesAndAffiliatedInvestments
63896
dba Increase Decrease In Variation Margin
IncreaseDecreaseInVariationMargin
-2683457
dba Increase Decrease In Variation Margin
IncreaseDecreaseInVariationMargin
-13146372
us-gaap Increase Decrease In Dividends Receivable
IncreaseDecreaseInDividendsReceivable
-188975
us-gaap Increase Decrease In Dividends Receivable
IncreaseDecreaseInDividendsReceivable
-144512
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-55256
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-276888
us-gaap Increase Decrease In Payables To Broker Dealers
IncreaseDecreaseInPayablesToBrokerDealers
2355
us-gaap Increase Decrease In Payables To Broker Dealers
IncreaseDecreaseInPayablesToBrokerDealers
2857
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
124681167
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
319420472
us-gaap Payments Of Dividends
PaymentsOfDividends
336157
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
96376442
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
95514366
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
225442518
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
414934838
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-129402233
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-319420472
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-4721066
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4721066
us-gaap Interest Paid Net
InterestPaidNet
159882
us-gaap Interest Paid Net
InterestPaidNet
109570
CY2006Q3 dba Number Of Series Of Trusts
NumberOfSeriesOfTrusts
5
CY2015Q1 us-gaap General Partners Capital Account Units Outstanding
GeneralPartnersCapitalAccountUnitsOutstanding
40
dba Treasury Obligation Measurement Maximum Maturity Period
TreasuryObligationMeasurementMaximumMaturityPeriod
P12M
dba Minimum Number Of Creation Units Of Shares That Can Be Purchased
MinimumNumberOfCreationUnitsOfSharesThatCanBePurchased
1
dba Number Of Shares Issued Per Creation Unit
NumberOfSharesIssuedPerCreationUnit
50000
us-gaap Use Of Estimates
UseOfEstimates
<div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">B.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Accounting Estimates</span></div></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates by a significant amount. In addition, the Fund monitors for material events or transactions that may occur or become known after the period-end date and before the date the financial statements are issued.</span></p>
CY2024Q3 us-gaap Distributed Earnings
DistributedEarnings
0
us-gaap Distributed Earnings
DistributedEarnings
0
CY2023Q3 us-gaap Distributed Earnings
DistributedEarnings
0
us-gaap Distributed Earnings
DistributedEarnings
0
CY2024Q3 us-gaap Other Nonrecurring Expense
OtherNonrecurringExpense
0
us-gaap Other Nonrecurring Expense
OtherNonrecurringExpense
0
CY2023Q3 us-gaap Other Nonrecurring Expense
OtherNonrecurringExpense
0
us-gaap Other Nonrecurring Expense
OtherNonrecurringExpense
0
CY2024Q3 dba Average Charges Paid To Broker Per Round Turn Trade Maximum
AverageChargesPaidToBrokerPerRoundTurnTradeMaximum
7
dba Average Charges Paid To Broker Per Round Turn Trade Maximum
AverageChargesPaidToBrokerPerRoundTurnTradeMaximum
7
CY2023Q3 dba Average Charges Paid To Broker Per Round Turn Trade Maximum
AverageChargesPaidToBrokerPerRoundTurnTradeMaximum
7
dba Average Charges Paid To Broker Per Round Turn Trade Maximum
AverageChargesPaidToBrokerPerRoundTurnTradeMaximum
7
dba Management Fee Per Annum Of Daily Net Assets
ManagementFeePerAnnumOfDailyNetAssets
0.0085
CY2024Q3 us-gaap Investment Company Contractual Fee Waived
InvestmentCompanyContractualFeeWaived
87709
us-gaap Investment Company Contractual Fee Waived
InvestmentCompanyContractualFeeWaived
276023
CY2023Q3 us-gaap Investment Company Contractual Fee Waived
InvestmentCompanyContractualFeeWaived
118617
us-gaap Investment Company Contractual Fee Waived
InvestmentCompanyContractualFeeWaived
352996
us-gaap Due To And From Broker Dealers And Clearing Organizations Disclosure
DueToAndFromBrokerDealersAndClearingOrganizationsDisclosure
<p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 5 – Deposits with Commodity Broker and Custodian</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Fund defines cash as cash held by the Custodian. There were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> cash equivalents held by the Fund as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">September 30, 2024 and December 31, 2023. The Fund considers investments in money market funds to be investments in securities and, accordingly, includes them in its Schedule of Investments.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Fund may deposit cash, United States Treasury Obligations, T-Bill ETFs and money market mutual funds with the Commodity Broker as margin, to the extent permissible under CFTC rules. The combination of the Fund’s deposits with its Commodity Broker of cash and United States Treasury Obligations and the unrealized profit or loss on open futures contracts represents the Fund’s overall equity in its broker trading account. To meet the Fund’s maintenance margin requirements, the Fund holds United States Treasury Obligations with the Commodity Broker. The Fund transfers cash to the Commodity Broker to satisfy variation margin requirements. The Fund earns interest on any excess cash deposited with the Commodity Broker and incurs interest expense on any deficit balance with the Commodity Broker.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The brokerage agreement with the Commodity Broker provides for the net settlement of all financial instruments covered by the agreement in the event of default or termination of any one contract. The Managing Owner will utilize any excess cash held at the Commodity Broker to offset any realized losses incurred in the commodity futures contracts, if available. To the extent that any excess cash held at the Commodity Broker is not adequate to cover any realized losses, a portion of the United States Treasury Obligations and T-Bill ETFs, if any, on deposit with the Commodity Broker will be sold to make additional cash available. For financial reporting purposes, the Fund offsets financial assets and financial liabilities that are subject to legally enforceable netting arrangements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Fund’s remaining cash, United States Treasury Obligations, T-Bill ETFs and money market mutual fund holdings are on deposit with the Custodian. The Fund is permitted to temporarily carry a negative or overdrawn balance in its account with the Custodian. The Fund incurs interest expense on any overdraft balance with the Custodian. Such balances, if any at period-end, are shown on the Statements of Financial Condition under the payable caption </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Due to custodian</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Because the Fund’s assets are maintained with the Commodity Broker and Custodian, the distress, impairment or failure of the Commodity Broker or Custodian could result in the loss of or delay in access to Fund assets.</span></p>
CY2024Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2024Q3 us-gaap Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
297686525
CY2024Q3 dba Financial Instruments Owned Exchange Traded Fund
FinancialInstrumentsOwnedExchangeTradedFund
119797308
CY2024Q3 dba Financial Instruments Owned Money Market Mutual Fund At Fair Value
FinancialInstrumentsOwnedMoneyMarketMutualFundAtFairValue
333671112
CY2024Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
751154945
CY2024Q3 dba Investment Securities Unrecognized Unrealized Appreciation
InvestmentSecuritiesUnrecognizedUnrealizedAppreciation
51783948
CY2024Q3 dba Investment Securities Unrecognized Unrealized Depreciation
InvestmentSecuritiesUnrecognizedUnrealizedDepreciation
22898448
CY2024Q3 dba Investment Securities Unrecognized Unrealized Appreciation Depreciation Net
InvestmentSecuritiesUnrecognizedUnrealizedAppreciationDepreciationNet
28885500
CY2024Q3 us-gaap Financial Instruments Owned At Fair Value
FinancialInstrumentsOwnedAtFairValue
780040445
CY2023Q4 us-gaap Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
342956644
CY2023Q4 dba Financial Instruments Owned Exchange Traded Fund
FinancialInstrumentsOwnedExchangeTradedFund
119734949
CY2023Q4 dba Financial Instruments Owned Money Market Mutual Fund At Fair Value
FinancialInstrumentsOwnedMoneyMarketMutualFundAtFairValue
248080509
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
710772102
CY2023Q4 dba Investment Securities Unrecognized Unrealized Appreciation
InvestmentSecuritiesUnrecognizedUnrealizedAppreciation
15443843
CY2023Q4 dba Investment Securities Unrecognized Unrealized Depreciation
InvestmentSecuritiesUnrecognizedUnrealizedDepreciation
32743090
CY2023Q4 dba Investment Securities Unrecognized Unrealized Appreciation Depreciation Net
InvestmentSecuritiesUnrecognizedUnrealizedAppreciationDepreciationNet
-17299247
CY2023Q4 us-gaap Financial Instruments Owned At Fair Value
FinancialInstrumentsOwnedAtFairValue
693472855
dba Minimum Number Of Creation Units Of Shares That Can Be Purchased
MinimumNumberOfCreationUnitsOfSharesThatCanBePurchased
1
dba Number Of Shares Issued Per Creation Unit
NumberOfSharesIssuedPerCreationUnit
50000
dba Minimum Number Of Creation Units Of Shares That Can Be Redeemed
MinimumNumberOfCreationUnitsOfSharesThatCanBeRedeemed
1
dba Number Of Shares Redeemable Per Creation Unit
NumberOfSharesRedeemablePerCreationUnit
50000
CY2024Q2 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
23.92
CY2023Q2 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
21.10
CY2023Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
20.74
CY2022Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
20.16
CY2024Q3 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
1.86
CY2023Q3 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
0.08
us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
4.53
us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
0.64
CY2024Q3 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.27
CY2023Q3 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.24
us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.78
us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.62
CY2024Q3 us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
2.13
CY2023Q3 us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
0.32
us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
5.31
us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
1.26
CY2024Q3 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
26.05
CY2023Q3 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
21.42
CY2024Q3 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
26.05
CY2023Q3 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
21.42
CY2024Q2 dba Market Value Per Share
MarketValuePerShare
23.81
CY2023Q2 dba Market Value Per Share
MarketValuePerShare
21.08
CY2023Q4 dba Market Value Per Share
MarketValuePerShare
20.73
CY2022Q4 dba Market Value Per Share
MarketValuePerShare
20.15
CY2024Q3 dba Market Value Per Share
MarketValuePerShare
26.10
CY2023Q3 dba Market Value Per Share
MarketValuePerShare
21.40
CY2024Q3 dba Market Value Per Share
MarketValuePerShare
26.10
CY2023Q3 dba Market Value Per Share
MarketValuePerShare
21.40
CY2024Q3 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.0435
CY2023Q3 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.0441
us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.0439
us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.0396
CY2024Q3 us-gaap Investment Company Expense Ratio Including Voluntary Fee Waiver
InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver
0.0089
CY2023Q3 us-gaap Investment Company Expense Ratio Including Voluntary Fee Waiver
InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver
0.0086
us-gaap Investment Company Expense Ratio Including Voluntary Fee Waiver
InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver
0.0088
us-gaap Investment Company Expense Ratio Including Voluntary Fee Waiver
InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver
0.0088
CY2024Q3 dba Average Net Assets To Expenses Prior To Waivers
AverageNetAssetsToExpensesPriorToWaivers
0.0094
CY2023Q3 dba Average Net Assets To Expenses Prior To Waivers
AverageNetAssetsToExpensesPriorToWaivers
0.0092
dba Average Net Assets To Expenses Prior To Waivers
AverageNetAssetsToExpensesPriorToWaivers
0.0093
dba Average Net Assets To Expenses Prior To Waivers
AverageNetAssetsToExpensesPriorToWaivers
0.0093
CY2024Q3 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
0.0890
CY2023Q3 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
0.0152
us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
0.2560
us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
0.0625
CY2024Q3 dba Return At Market Value
ReturnAtMarketValue
0.0962
CY2023Q3 dba Return At Market Value
ReturnAtMarketValue
0.0152
dba Return At Market Value
ReturnAtMarketValue
0.2590
dba Return At Market Value
ReturnAtMarketValue
0.0620
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 dba Rule10 B51 Arr Modified Flag
Rule10B51ArrModifiedFlag
false
CY2024Q3 dba Non Rule10 B51 Arr Modified Flag
NonRule10B51ArrModifiedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-24-122588-index-headers.html Edgar Link pending
0000950170-24-122588-index.html Edgar Link pending
0000950170-24-122588.txt Edgar Link pending
0000950170-24-122588-xbrl.zip Edgar Link pending
dba-20240930.htm Edgar Link pending
dba-20240930.xsd Edgar Link pending
dba-ex31_1.htm Edgar Link pending
dba-ex31_2.htm Edgar Link pending
dba-ex32_1.htm Edgar Link pending
dba-ex32_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img238553616_0.jpg Edgar Link pending
img238553616_1.jpg Edgar Link pending
img238553616_2.jpg Edgar Link pending
img238553616_3.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
dba-20240930_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable